Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06795997 · ClinicalTrials.gov registry record · NA
Tobacco/Nicotine Purchase Patterns Across SES
A NA study of Smoking Behaviors and Smoking, Cigarette, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 663
- Enrollment target
- 1
- Study location
NCT06795997: Completed NA study of Smoking Behaviors and Smoking, Cigarette, sponsored by Virginia Polytechnic Institute and State University.
NCT06795997 is a NA study of Smoking Behaviors and Smoking, Cigarette that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 663 participants, above the 407-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06795997, a NA study of Smoking Behaviors and Smoking, Cigarette, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 663 participants
- Enrollment target
- 1
- Study location
Study Summary
In a within-subject design, investigators will use the Experimental Tobacco Marketplace (ETM) to systematically impose 4 novel tobacco/nicotine tax proposals (Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-related taxes) covering a broad range of tax magnitudes. Participants will complete one control trial and all conditions (tax proposals) in the ETM with 5 trials each. Analyses will model the quantity of the product purchased as a function of tax tier (i.e., high, medium, no tax) and examine poly-tobacco purchasing.
Primary Outcome
Participants will make hypothetical purchases of tobacco products to use throughout the next 7 days
Conditions Studied
Interventions
- BEHAVIORAL Control Condition
- BEHAVIORAL Tax Conditions
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 663 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2025-03-25 |
| Phase | NA |
What the finished NCT06795997 record still lists
NCT06795997 is an interventional study that assigns participants to a tested intervention. The registered 663 participants enrollment target is mid-sized for trials with a published cap, above the 407-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (63% higher).
The record links to 3 conditions, with Smoking Behaviors appearing as the primary indexed condition, and to 2 interventions - of which Control Condition is the first listed.
NCT06795997 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06795997 about?
NCT06795997 is a clinical study titled "Tobacco/Nicotine Purchase Patterns Across SES". In a within-subject design, investigators will use the Experimental Tobacco Marketplace (ETM) to systematically impose 4 novel tobacco/nicotine tax proposals (Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-related taxes) covering a broad range of tax magnitudes. ...
What is the current status of trial NCT06795997?
This trial is currently completed. It is a NA study. The enrollment target is 663 participants. The study started on 2024-12-16. Estimated completion is 2025-03-25.
What conditions does trial NCT06795997 study?
This clinical trial studies the following conditions: Smoking Behaviors, Smoking, Cigarette, Smoking, Non-Tobacco Products.
What interventions are being tested in trial NCT06795997?
The interventions under investigation include: Control Condition (BEHAVIORAL), Tax Conditions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06795997?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06795997 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Behaviors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06795997's enrollment target sits among peer trials
663 5th of 21 higher than 17 of 21 other Smoking Behaviors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Behaviors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07164443 · 663 participants · Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
- NCT05254743 · 662 participants · Phase 3
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- NCT04064060 · 665 participants · Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI